Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Pancreatic Neoplasms 4Neoplasms 2Stomach Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Nasopharyngeal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hodgkin Disease 1Colorectal Neoplasms 1Castleman Disease 1

Interventions

Nivolumab 3Cyclophosphamide 3pembrolizumab 2fludarabine phosphate 2durvalumab 2Specimen Handling 2Polymerase Chain Reaction 2Leucovorin 2Interleukin-2 2Imatinib Mesylate 2Gemcitabine 2Fluorouracil 2Doxorubicin 2Dasatinib 2Capecitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2venetoclax 1vactosertib 1trametinib 1tazemetostat 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1palbociclib 1olaparib 1neratinib 1motexafin gadolinium 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Nelfinavir × Gastrointestinal × Clear all
NCT02080416 2016-06-10

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Terminated
1 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Castleman Disease, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Neoplasms, Sarcoma, Sarcoma, Kaposi, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡